---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-102914"
form_type: "8-K"
ticker: "LYRA"
cik: "0001327273"
company_name: "Lyra Therapeutics, Inc."
filed_at: "2024-04-19T23:59:59+00:00"
generated_at: "2026-06-03T15:20:21.610118+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Director Edward T. Anderson resigns from Lyra board; Snyderman appointed to Audit Committee

## Summary
- Edward T. Anderson resigned from Lyra's Board, Audit Committee, and Compensation Committee effective April 15, 2024.
- Nancy L. Snyderman was appointed to the Audit Committee on April 15, 2024, filling the vacancy.
- Anderson had been a Board member since 2019 and an investor since 2006; no reason for departure given.

## SEC filing metadata
- accession: 0001193125-24-102914
- form_type: 8-K
- ticker: LYRA
- cik: 0001327273
- company_name: Lyra Therapeutics, Inc.
- filed_at: 2024-04-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1327273/000119312524102914/0001193125-24-102914-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1327273/000119312524102914/d825056d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-102914
- JSON: https://secwatch.observer/filing/0001193125-24-102914.json
- Plain text: https://secwatch.observer/filing/0001193125-24-102914.txt

## Key facts
- Executive change
  Edward T. Anderson resigned as Director at Lyra Therapeutics, Inc..
  - Action: resigned
  - Role: Director
  source text: On April 15, 2024, Edward T. Anderson resigned from the Board of Directors (the “ Board ”) of Lyra Therapeutics, Inc. (the “ Company ”) as well as the Audit Committee and Compensation Committee of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1327273/000119312524102914/0001193125-24-102914-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.